<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04073446</url>
  </required_header>
  <id_info>
    <org_study_id>A4068</org_study_id>
    <nct_id>NCT04073446</nct_id>
  </id_info>
  <brief_title>Focal Pain Outcomes Using Configurations Applied for Lateral Stimulation</brief_title>
  <acronym>FOCAL</acronym>
  <official_title>Focal Pain Outcomes Using Configurations Applied for Lateral Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate programming modalities at various targets for focal foot and knee pain relief.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 31, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in overall pain intensity</measure>
    <time_frame>up to 1.5 year post implant</time_frame>
    <description>Change in overall pain intensity from Baseline to end of each Period and End of Study (NRS)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">13</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Dorsal Column (DC) Perception</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of DC Perception based programming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal Root (DR) Perception</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of DR Perception based programming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal Column (DC) Sub-perception</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of DC sub-perception based programming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dorsal Root (DR) Sub-perception</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of DR sub-perception based programming</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal Cord Stimulation</intervention_name>
    <description>Patients eligible for SCS</description>
    <arm_group_label>Dorsal Column (DC) Perception</arm_group_label>
    <arm_group_label>Dorsal Column (DC) Sub-perception</arm_group_label>
    <arm_group_label>Dorsal Root (DR) Perception</arm_group_label>
    <arm_group_label>Dorsal Root (DR) Sub-perception</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Average unilateral foot or knee pain intensity of 6 or greater on a 0-10 numerical
             rating scale at Baseline Visit based on 7-day average NRS score

          -  Subject signed a valid, EC-approved informed consent form (ICF)

          -  Willing and able to comply with all protocol-required procedures and
             assessments/evaluations

          -  18 years of age or older when written informed consent is obtained

        Key Exclusion Criteria:

          -  Significant cognitive impairment at Screening that, in the opinion of the
             Investigator, would reasonably be expected to impair the study candidates to
             participate in the study

          -  Participating (or intends to participate) in another drug or device clinical trial
             that may influence the data that will be collected for this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Keesey</last_name>
    <phone>661-949-4175</phone>
    <email>Diane.Keesey@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshini Jain</last_name>
    <phone>661-949-4350</phone>
    <email>roshini.jain@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>98040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roshini Jain</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2019</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal Cord Stimulation</keyword>
  <keyword>Chronic Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

